Answer
Fruquintinib may cause foetal harm, with animal studies showing reproductive toxicity including foetal malformations; no clinical pregnancy data exist, and use should be avoided unless the woman's condition requires treatment after careful consideration of maternal benefits and foetal risks.
Sources for this answer
- FRUZAQLA 1 mg hard capsulesTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked